48 articles in this topic
Breakthrough blood test combining four biomarkers catches deadly pancreatic cancer early when treatment works best, detecting 87.5% of stage I/II cases.
Scientists discover how small cell lung cancer uses inflammation to become more aggressive and resistant to treatment.
Scientists discover why identical cancer treatments work for some patients but fail for others, revealing hidden drug reservoirs in cells.
New poll reveals major knowledge gap about processed meat and colorectal cancer, but plant-based diets can cut risk by 22%.
New research suggests people eating organic foods most frequently have significantly lower cancer rates than conventional food consumers.
Plant compounds naturally target multiple cancer pathways simultaneously, offering advantages over pharmaceutical approaches.
Glycidol, a toxic compound formed during oil refining, damages DNA and may explain higher cancer rates in fried food consumers.
New trial data reveals AstraZeneca's experimental in vivo CAR-T therapy showed early responses in multiple myeloma patients but resulted in one death.
New biotech innovations are advancing prostate cancer therapy with promising approaches for better patient outcomes.
Key biotech companies developing T cell engager therapies that redirect immune cells to fight cancer more effectively.
Australian biotech company creates targeted treatment that attacks malignant plasma cells while sparing healthy ones in multiple myeloma patients.
Revolutionary CRISPR technique bypasses lab manufacturing by programming immune cells to fight cancer directly in the body.
